124 results on '"Wacker, Margarethe"'
Search Results
2. Association of generic health-related quality of life (EQ-5D dimensions) and inactivity with lung function in lung-healthy German adults: results from the KORA studies F4L and Age
Catalog
Books, media, physical & digital resources
3. The revised GOLD 2017 COPD categorization in relation to comorbidities
4. External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting
5. Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
6. Impact of chronic ischemic heart disease on the health care costs of COPD patients – An analysis of German claims data
7. Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study
8. Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens
9. Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios
10. Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
11. Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study
12. Additional file 1: of Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study
13. Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
14. Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
15. Cost variations of asthma over 10 years in adults
16. Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
17. Additional file 3: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
18. Additional file 5: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
19. Additional file 4: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
20. Additional file 1: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
21. Additional file 2: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
22. Cost variations of asthma over 10 years in adults
23. Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort
24. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
25. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
26. Costs and health-related quality of life in COPD patients with α-1-antitrypsin deficiency: results of the COSYCONET cohort
27. Late Breaking Abstract - The socio-economic cost of asthma, COPD and chronic bronchitis in Europe
28. What predicts a deterioration of generic and disease-specific health-related quality of life in COPD? First longitudinal results of the COSYCONET cohort
29. Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort
30. Disease-specific medication, patient-reported diagnoses and their relation to COPD severity for common comorbidities in COPD
31. Gesundheitswissenschaftliche Forschung mit primärärztlichen Routinedaten der elektronischen Patientenakte: das BeoNet-Register
32. Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies
33. Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
34. Prevalence of common diseases in COPD patients versus lung-healthy control subjects: Results from the German COSYCONET study
35. External validation of exacerbation and mortality outcomes of health economic decision models for COPD
36. Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication
37. Can disease-specific questionnaires describe the effect of comorbidities on health-related quality of life in patients with COPD? A comparison of disease-specific and generic questionnaires in the COSYCONET cohort
38. Better understanding of the health care costs of lung cancer and the implications
39. Gesundheitswissenschaftliche Forschung mit primärärztlichen Routinedaten der elektronischen Patientenakte: das BeoNet-Register.
40. Berücksichtigung von Komorbidität, Begleitmedikation und Alter in deutschen S3-Leitlinien
41. Assessing health-related quality of life in COPD: A comparison between one generic and two disease-specific instruments
42. The primary care routine data registry BeoNet: First pilot phase results for COPD research
43. Interim analysis of the EXCITING-ILD registry
44. Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review
45. Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
46. Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry—The EXCITING-ILD Registry
47. Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
48. Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
49. Health-related quality of life and chronic obstructive pulmonary disease in early stages – longitudinal results from the population-based KORA cohort in a working age population
50. The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.